Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients

BACKGROUND: Treatment of hyperphosphataemia is the primary goal of chronic kidney disease–mineral and bone disorder (CKD-MBD) management. This post hoc analysis of a randomized, Phase 3 study evaluated the effects of 1-year treatment with the phosphate binders sucroferric oxyhydroxide or sevelamer c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ketteler, Markus, Sprague, Stuart M, Covic, Adrian C, Rastogi, Anjay, Spinowitz, Bruce, Rakov, Viatcheslav, Walpen, Sebastian, Floege, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603395/
https://www.ncbi.nlm.nih.gov/pubmed/29846719
http://dx.doi.org/10.1093/ndt/gfy127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603395/
https://www.ncbi.nlm.nih.gov/pubmed/29846719
http://dx.doi.org/10.1093/ndt/gfy127

Ejemplares similares